BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15980225)

  • 41. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
    Russo PA; Bouchard CS; Galasso JM
    Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye.
    Khanal S; Tomlinson A; Pearce EI; Simmons PA
    Cornea; 2007 Feb; 26(2):175-81. PubMed ID: 17251808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schirmer tear test, phenol red thread tear test, eye blink frequency and corneal sensitivity in the guinea pig.
    Trost K; Skalicky M; Nell B
    Vet Ophthalmol; 2007; 10(3):143-6. PubMed ID: 17445074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome.
    Yoon KC; Im SK; Park YG; Jung YD; Yang SY; Choi J
    Cornea; 2006 Apr; 25(3):268-72. PubMed ID: 16633024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses.
    McMonnies CW
    Cont Lens Anterior Eye; 2007 Mar; 30(1):37-51. PubMed ID: 17251052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits.
    El-Shazly AH; El-Gohary AA; El-Shazly LH; El-Hossary GG
    Acta Pharm; 2008 Jun; 58(2):163-73. PubMed ID: 18515226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased corneal sensitivity in patients with dry eye.
    Bourcier T; Acosta MC; Borderie V; Borrás F; Gallar J; Bury T; Laroche L; Belmonte C
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2341-5. PubMed ID: 15980220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous serum application in the treatment of neurotrophic keratopathy.
    Matsumoto Y; Dogru M; Goto E; Ohashi Y; Kojima T; Ishida R; Tsubota K
    Ophthalmology; 2004 Jun; 111(6):1115-20. PubMed ID: 15177961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exposure to a dry environment induces strain-specific responses in mice.
    Barabino S; Rolando M; Chen L; Dana MR
    Exp Eye Res; 2007 May; 84(5):973-7. PubMed ID: 17397831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
    Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of aniridia and dry eyes.
    Jastaneiah S; Al-Rajhi AA
    Ophthalmology; 2005 Sep; 112(9):1535-40. PubMed ID: 16023212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops.
    Christensen MT
    Adv Ther; 2008 Nov; 25(11):1191-9. PubMed ID: 18972076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers.
    Zhivov A; Kraak R; Bergter H; Kundt G; Beck R; Guthoff RF
    Curr Eye Res; 2010 Aug; 35(8):762-9. PubMed ID: 20673054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
    Oh HN; Kim CE; Lee JH; Yang JW
    Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.